| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 740259 | Null | 0.0462077035966081 | 0.36701149 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0462077035966081 | 0.55626086 |
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0462077035966081 | -0.12672918 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0462077035966081 | 0.44686373 |
| NSC 149286 | 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- | 0.0462077035966084 | 0.51513153 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0462077035966084 | 0.38965836 |
| NSC 20200 | [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride | 0.0462077035966084 | 0.41205467 |
| NSC 254677 | Phomazarin | 0.0462077035966084 | -0.18602989 |
| NSC 295641 | Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester | 0.0462077035966084 | 0.28702041 |
| NSC 304610 | Null | 0.0462077035966084 | 0.26597035 |